March 14, 2018 / 8:19 PM / 6 months ago

BRIEF-Arbutus Announces Corporate Update

March 14 (Reuters) - Arbutus Biopharma Corp:

* ARBUTUS ANNOUNCES CORPORATE UPDATE AND YEAR-END 2017 FINANCIAL RESULTS

* ARBUTUS BIOPHARMA CORP - ‍ARB-1467 PHASE II COMBINATION STUDY BEGINNING IN 1Q18​

* ARBUTUS BIOPHARMA CORP - ‍INTERIM ON-TREATMENT RESULTS FROM ARB-1467 STUDY ARE EXPECTED IN SECOND HALF OF 2018, FOLLOWED BY FINAL RESULTS IN 2019 ​

* ARBUTUS BIOPHARMA CORP - ‍AB-452 TO ENTER CLINICAL DEVELOPMENT​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below